These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9269651)

  • 1. Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
    Van Landeghem GF; D'Haese PC; Lamberts LV; Barata JD; De Broe ME
    Nephrol Dial Transplant; 1997 Aug; 12(8):1692-8. PubMed ID: 9269651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.
    Barata JD; D'Haese PC; Pires C; Lamberts LV; Simões J; De Broe ME
    Nephrol Dial Transplant; 1996 Jan; 11(1):125-32. PubMed ID: 8649620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT; Milliner DS; Johnson WJ
    Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium.
    Altmann P; Plowman D; Marsh F; Cunningham J
    Lancet; 1988 May; 1(8593):1012-5. PubMed ID: 2896867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG; Acuña Aguerre G; Fernández Martín JL; Mouzo R; Cannata Andía JB
    Nephrol Dial Transplant; 1994; 9(10):1431-4. PubMed ID: 7816256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative studies of aluminium binding species in human uremic serum by fast protein liquid chromatography coupled with electrothermal atomic absorption spectrometry.
    Soldado Cabezuelo AB; Blanco González E; Sanz-Medel A
    Analyst; 1997 Jun; 122(6):573-7. PubMed ID: 9282403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aluminum osteopathy--experience with therapy].
    Sulková S
    Vnitr Lek; 1993 May; 39(5):459-63. PubMed ID: 8351877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U
    Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminium and silicon speciation in human serum by lon-exchange high-performance liquid chromatography-electrothermal atomic absorption spectrometry and gel electrophoresis.
    Wróbel K; González EB; Wróbel K; Sanz-Medel A
    Analyst; 1995 Mar; 120(3):809-15. PubMed ID: 7741232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
    Verpooten GA; D'Haese PC; Boelaert JR; Becaus I; Lamberts LV; De Broe ME
    Nephrol Dial Transplant; 1992; 7(9):931-8. PubMed ID: 1328941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
    Lechleitner P; Gmeiner R; Beck G; König P
    Wien Med Wochenschr; 1987 Aug; 137(14-15):355-60. PubMed ID: 3673100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D; Simícková J; Kubátko J; Syrovátka P
    Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid aluminum levels following deferoxamine.
    Ellenberg R; King AL; Sica DA; Posner M; Savory J
    Am J Kidney Dis; 1990 Aug; 16(2):157-9. PubMed ID: 2382654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis.
    Allain P; Chaleil D; Mauras Y; Beaudeau G; Varin MC; Poignet JL; Ciancioni C; Ang KS; Cam G; Simon P
    Clin Chim Acta; 1987 Dec; 170(2-3):331-8. PubMed ID: 3436066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.
    D'Haese PC; Couttenye MM; Goodman WG; Lemoniatou E; Digenis P; Sotornik I; Fagalde A; Barsoum RS; Lamberts LV; De Broe ME
    Nephrol Dial Transplant; 1995 Oct; 10(10):1874-84. PubMed ID: 8592597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of aluminium removal by desferrioxamine VIA hemodialysis in a case with aluminium bone disease.
    Terao N; Sizuki M; Ando Y; Kato K; Asano Y; Hosoda S; Suka T
    Nihon Jinzo Gakkai Shi; 1985 Sep; 27(9):1305-12. PubMed ID: 4087551
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrafiltrable aluminium after very low doses of desferrioxamine.
    Canteros A; Díaz-Corte C; Fernández-Martín JL; Gago E; Fernández-Merayo C; Cannata J
    Nephrol Dial Transplant; 1998 Jun; 13(6):1538-42. PubMed ID: 9641189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desferrioxamine induced aluminium removal in haemodialysis.
    Bonal J; Montoliu J; Löpez Pedret J; Bergadä E; Andrew L; Bachs M; Revert L
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():366-70. PubMed ID: 3991524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)].
    Günther K; Winnefeld K; Stein G; Sperschneider H; Schröter H; Fünfstück R
    Z Urol Nephrol; 1986 Oct; 79(10):569-76. PubMed ID: 3811645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.